Olivier Tak

Junior partner

Olivier Tak has a background in both Nanobiology and Medicine. Prior to co-initiating Curie Capital in 2018 and joining the first fund as an investment analyst, Olivier worked at De Groot Family Office as an analyst on their biotechnology portfolio. During his studies at Delft University of Technology and Erasmus Medical Center, Olivier did research at the Francis Crick Institute and Harvard Medical School. Besides his studies he conducted internships at Medicxi and Kempen & Co.

Our other team members

We are a venture capital firm specializing in seed investments for innovative early-stage companies. Curie Capital typically takes on the role of lead investor. Our team comprises life science experts and business analysts who offer guidance to life science companies throughout the entire research and development process.

Han de Groot, MSc


Mariette van der Velden, MSc


Thom Frielink, MSc, MBA